Research Article

Plasmid Mediated Quinolone Resistance in Enterobacteriaceae: A Review

Ezeh, P. A.1*, Olayinka, B. O1, Bolaji, R.O.1
1 Department of Pharmaceutics and Pharmaceutical Microbiology, Faculty of Pharmaceutical sciences, Ahmadu Bello University, Zaria, Kaduna
* Corresponding author: Peace.ezehamara@gmail.com
Published: Jun, 2020
DOI: 10.67614/njm.2020.bboz4h02
Pages: 4962-4976

Abstract

Antimicrobial resistance (AMR) is a global problem which is hindering treatment of bacterial infections. Evaluation of the prevalence of PMQR genes is important in terms of selection of antibiotics for treatment options. The aim of this work is to review prior data on PMQR with a view of evaluating the prevalence of PMQR genes in Enterobacteriaceae and to identify the knowledge gap if any. This systematic review was conducted in line with the Preferred Reporting Items of Systematic Reviews and Meta-analyses (PRISMA) guideline. Pubmed and Ajol online databases were primarily searched for relevant articles. The eligible articles were evaluated using a set of eligibility criteria. Ninety five (95) full text article were selected for screening using the eligibility criteria. Twenty four (24) articles with majority emanating from Iran and China and only one article reporting study carried out in Nigeria where selected for qualitative synthesis for this review. The PMQR genes include qnr, aac (6’) Ib-cr and qepA gene. 46% of the articles focused on only one type of PMQR gene but not any of the two or three together while 54% screened for more than one type of the PMQR genes. Most frequently isolated PMQR gene is Qnr gene (96%) followed by Aac (6’)Ib-cr gene (46%) and QepA gene (13%). High occurrence of QepA gene (18.7%) was reported in the only study in Nigeria.The review showed a high prevalence of PMQR genes especially in Nigeria. With the limited studies evaluating the burden of PMQR there is also the need for the establishment of antibiotics surveillance policies especially in Nigeria.

Keywords

Plasmid-Mediated Quinolone Resistance Enterobacteriaceae aac(6’)-Ib-cr” “qnr” “qepA” “Antibiotic resistance

References

  1. Ajayi, A.O., Otuduro, A.O., Olowe, O.A., Odeyemi, A.T and Famurewa, O. (2012) Plasmid-mediated fluoroquinolone-resistance QnrA and QnrB genes among Escherichia coli from cattle in Ado-Ekiti, Western Nigeria. Indian Med J. 61(8):784-8.
  2. Ball P (2000). 'Quinolone generations: natural history or natural selection?'. J. Antimicrob. Chemother. 46 Suppl T1 3): 17–24
  3. Beceiro A, Tomas M, and Bou G. (2013) Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World? Clinical Microbiology Reviews 26(2): 185–230
  4. Bhattachary, D., Bhattacharjee, H., Thamizhmani, R., Sayi, D. S., Bharadwaj, A. P., Singhania, M., Sugunan, A. P., and Roy, S. (2013) Prevalence of the plasmid-mediated quinolone resistance determinants among clinical isolates of Shigella sp. in Andaman & Nicobar Islands, India. Letters in Applied Microbiology; 53(2): 247–251
  5. Blanco, J. E., Blanco, M., Mora, A. and Blanco, J. (1997) Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain. Journal of Clinical Microbiology, 35 (8) 2184-2185;
  6. Blanco, R., Gtiens, M., Puhler, M., and Schluter, A. (2011). Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant. Antimicrob. Agents Chemother. 55, 3075–3080.
  7. Bonemann, G., Gtiens, M., Puhler, A., and Schluter, A. (2011). Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant. Antimicrob. Agents Chemother. 55, 3075–3080.
  8. Buckner, M.M.C., Ciusa, M.L and Piddock, L.J.V. (2018) Strategies to combat antimicrobial and plasmid curing FEMS Microbiology Reviews, fuy031, 42: 781–804
  9. Cabello, F.C. (2006) Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environmental Microbiology, 8:1137–44
  10. Cambau E, Lascols C and Sougakoff W. (2006) Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005. Clin Microbiol Infect; 12: 1013–1020.
  11. Cano, M.E., Rodri'guez-Marti'nez, J.M., Agu'ero, J., Pascual, A., Calvo, J., Garci'a-Lobo, J.M., Velasco, C., Francia, M.V. and Marti'nez-Marti'nez, L. (2009) Detection of Plasmid-Mediated Quinolone Resistance Genes in Clinical Isolates of Enterobacter spp. in Spain. Journal of Clinical Microbiology, 47(7): 2033–2039
  12. Cattoir, V., Poirel, L., Rotimi, V., Soussy, C.J and Nordmann, P. (2007). Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. Journal of Antimicrobial Chemotherapy. 60:394-397.
  13. Cavaco LM, Hasman H, Xia S, and Aarestrup FM. (2009) qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother.;53:603–608.
  14. Center for Disease Control and Prevention (2013) Antibiotics resistance Threats in the United States. Meeting the Challenges of Drug-Resistant Diseases in Developing Countries Committee on Africa, Global Health, Human Rights, and International Organizations
  15. Chen, C. R., Malik, M., Snyder, M. and Drlica, K. (1996) DNA gyrase and topoisomerase IV on the bacterial Chromosome: quinolone-mediated DNA cleavage. Journal of Molecular Biology, 258:627–37.
  16. Coque T. M., Novais, A., Carattoli, A., Poirel, L., Pitout, J., Peixect, L., Baquero, F., Canton, R. and Nordmann, P. (2008). International dissemination of clonally-related Escherichia coli strains expressing the extended-spectrum b-lactamase CTX-M-15. Emerging Infectious Diseases, 14(2)
  17. Cruz, G. R., Radice, M., Sennati, S., Pallecchi, L., Rossolini, G. M., Gutkind, G. and Ajandro Di Conza, J. (2013) Prevalence of plasmid-mediated quinolone resistance determinants among Enterobacteriaceae in Argentina. Ineri Ostwaldo Cruz; 108(7): 924–927
  18. Deng, Y., Zeng, Z., Tian, W., Yang, T. and Liu, J. (2013) Prevalence and characteristics of rmtB and qepA in Escherichia coli isolated from diseased animals in China. Front. Microbiol; 00198
  19. Drlica, K and Zhao, X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and Molecular Biology Reviews, 61:377–92.
  20. Drlica, K, Malik, M, Kerns, R. J, and Zhao, X. (2008) Quinolone-mediated bacterial death. Antimicrobial Agents and Chemotherapy, 52:385-92.
  21. Du, X. D., Li, D. X., Hu, G. Z., Wang, Y., Shang, Y. H, Wu, C. M., Liu, H. B., and Li, X. S. (2012). Tn1548-associated armA is co-located with pmrAB2, aac(6')-Ib-cr and blaCTX-M-3 on an IncFII plasmid in a Salmonella enterica subsp. enterica serovar Paratyphi B strain isolated from chickens in China. J. Antimicrob. Chemother. 67, 246–248.
  22. Eftekhar, F. and Seyedpour, S. (2014). Susceptibility and Detection of qnr and aac(6')-Ib-cr Genes in Community Isolates of Klebsiella pneumoniae. Jundishapur J Microbiol.7(7): e11136.
  23. Eftekhar, F. and Seyedpour, S. (2015). Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia clinical isolates. Jundishapur J Microbiol. 8(4): e14204.
  24. Emmerson, A.M. and Jones,A.M (2003) The quinolones: decades of development and use. Journal of Antimicrobial Chemotherapy ,51, Suppl. S1, 13–20
  25. Fonseca EL and Vicente AC (2013) Epidemiology of qnrVC alleles and emergence out of the Vibrionaceae family. J Med Microbiol.;62:1628–1630.
  26. Fonseca EL, Dos Santos Freitas F, Vieira VV, and Vicente AC (2008) New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg Infect Dis;14:1129–1131.
  27. Forcella, C., Beltegrini, C., Colenza, G., Segatore, B., Calabrese, M., Amicosante, G., and Perilli, M. (2010). QnrB9 in association with TEM-116 extended-spectrum β-lactamase in Citrobacter freundii isolated from sewage effluent: first report from Italy. J. Chemother. 22, 243–245.
  28. Fortini, D., Fashae, K., Garcı'a-Ferna'ndez, A., Villa, L. and Carattoli, A. (2011) Plasmid-mediated quinolone resistance and b-lactamasesin Escherichia coli from healthy animals from Nigeria. J Antimicrob Chemother; 66: 1269–1272
  29. Gay K, Robcisek A and Strahilevitz J. (2006) Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis; 43: 297–304.
  30. Grillon, A., Schramm, F., Kleinberg, M., and Jehl, F. (2016). Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia clinical isolates in resistance in clinical isolates of Gram-negative pathogens from Nigeria.
  31. Meek, R. W., Vyas, H. and Piddock, L. J. (2015). Nonmedical Uses of Antibiotics: Time to Restrict Their Use? PLoS Biology, 13(10): e1002266.
  32. Meek, R.W., Vyas, H. and Piddock, L.J. (2015) Nonmedical uses of antibiotics: time to restrict their use? PLoS Biology 13(10): e1002266
  33. Moher D, Liberati A, Tetzlaff J, Altman DG, and Grp P. (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (Reprinted from Annals of Internal Medicine). Phys ther.;89(9):873-80.
  34. Munn Z, Moola S, Lisy K, Riitano D and Tufanaru C. (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and incidence data. Int J Evid Based Health.;13(3):147-153
  35. Nazic H, Poirel L, and Nordmann P (2005) Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob Agents Chemother; 49: 2146–2147.
  36. Nordmann P and Poirel L. (2005) Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother; 56: 463–469
  37. Nsikan S. U., Akan, O. D., James, I. I., Agbo, B. E., Anthony, U. (2019) Multi-Drug Resistant and Plasmid-Mediated Salmonella enterica isolated from Shellfish in Iko Creek, Nigeria. Journal of Advances in Microbiology, 14(1), 1-8.
  38. O'Neill, J. (2016) Tackling Drug-Resistant Infections Globally: Final Report and Recommendations on Antimicrobial Resistance. 2016, https://arm-review.org/publications.html.
  39. Ogbolu DO; Aollu AO; Anorue MC; Daini OA; and Oluwadun A. (2011) Distribution of plasmid-mediated quinolone resistance in Gram-negative bacteria in Nigeria. J Pathol Microbiol; 59(3):322-6
  40. Ogbolu, D.O., Daini, O. A., A.Ogunledun, O., A.O.Alli, O. A. and Webber, M. A. (2011) High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria.
  41. Robicsek A, Jacoby GA, and Hooper DC. (2006) 'The worldwide emergence of plasmid-mediated quinolone resistance'. Lancet Infect Dis.; 6:629–40.
  42. Robicsek A, Strahilevitz, J. and Jacoby, G., Macielag, M, Abbanat, D, Park, C. H, Bush, K. and Hooper, D. C. (2006). Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nature Medicine, 12: 19–20.
  43. Rodri'guez-Marti'nez, J. M., Pascual, A., Garcı'a, I. and Martinez-Martinez, L. (2003). Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type β-lactamase. Journal of Antimicrobial Chemotherapy, 52:703–5.
  44. Rodríguez-Martinez JM, Velasco C, and Pascual A. (2006) Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. Clin Microbiol Infect; 12: 440–445.
  45. Ruiz, J., Castro, L., Calabuig, E. and Salavert, M. (2017) Non-antibiotic treatment for infectious diseases Rev Esp Quimioter;30 (Suppl. 1): 66-71
  46. Sanchez-Cespedes, J., Blasco, M. D., Marti, S., Alba, V., Alcaide, E., Esteve, C., and Vila, J. (2008). Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate. Antimicrob. Agents Chemother. 52, 2990–2991.
  47. Soussy, C. J., Nguyen, J., Goldstein, F., Dabernat, H., Andremont, A., Leclercq, R., Drugeon, H., Etienne, J., Rio, Y. and Courvalin, P. (2003) In vitro antibacterial activity of moxifloxacin against Enterobacter species: a multicentre study. Clinical Infection 9(10)
  48. Strahilevitz, J., Engelstein, D., Adler, A. and Temper, V. and E. Moses, C. Block, and A. Robicsek. (2007) Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob. Agents Chemother. 51:3001-3003.
  49. Sumrall E.T, Gallo, E.B, Aboderin, A.O, Lamikanra, A. and Okeke, I.N. (2014) Dissemination of the Transmissible Quinolone-Resistance Gene qnrS in PloS One 9(10): e110729.
  50. Tankovic, J., Bachoual, R. Ouabdesselam, S. Baudajaria and Soussy C. (1999) in vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic Gram negative Bacilli and Enterococcus faecalis. Journal of Antimicrobial Chemotherapy 43:19-29
  51. Tarchouna, M., Ferjani, A., Marzouk, M., Guedda I. and Boukadida, J. (2015) Prevalence of Plasmid-Mediated Quinolone Resistance Determinants among Clinical Isolates of Escherichia coli in a Tunisian Hospital. International Journal of Current Microbiology and Applied Sciences, 4(3):195-206
  52. Tillotson G. (2015) Antimicrobial resistance: what's the problem? Lancet Infect Dis; 15: 758–60
  53. Touati A, Brasme L, and Benallaoua S. (2008) First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagn Microbiol Infect Dis; 60: 287–290.
  54. Tran, J. H, and Jacoby, G. A. (2002) Mechanism of plasmid-mediated quinolone resistance. Proceedings of National Academy of Sciences of USA;99:5638-42.
  55. Van Boeckel, T.P, Brower, C, Gilbert, M, Grenfell, B.T, Levin, S.A, Robinson, T.P, Teillant, A. and Laxminarayan, R. (2015) Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA; 112:5649–54.
  56. Van Boeckel, T.P, Gandra, S, Ashok, A, Caudron, Q, Grenfell, B.T, Levin, S.A. and Laxminarayan, R. (2014) Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis;14:742–50.
  57. Van Boeckel, T.P, Glennon, E.E, Chen, D, Gilbert, M, Robinson, T.S, Grenfell, B.T, Levin, S.A, Bonhoeffer, S. and Laxminarayan, R. (2017) Reducing antimicrobial use in food animals. Science; 357:1350–2.
  58. Veldman, K, Cavaco, L. M, Mevius, D, Battisti, A, Franco, A, Botteldoorn, N, Bruneau, M, Perrin-Guyomard, A, Cerny, T, De Frutos Escobar, C, Guerra, B, Schroeter, A, Gutierez, M, Hopkins, K, Myllyniemi, A, Sunde, D, Wasyl, D. and Aarestrup, F. M. (2011). International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries. J. Antimicrob. Chemother. 66, 1278–1286.
  59. Wagman, A.S. and Wentland, M. P. (2007) Therapeutic Areas II: Cancer, Infectious, Inflammation & Immunology and Dermatology. Comprehensive Medicinal Chemistry II. Elsevier ISBN: 0-08-044513-6
  60. Wang, M, Tran, J. H., Jacoby, G. A, Zhang, Y, Wang, F. and Hooper, D. C. (2003). Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China. Antimicrobial Agents and Chemotherapy, 47(7): 2242–2248
  61. World Health Organization (2012) Prevention of Hospital-Acquired Infections: A Practical Guide. WhoCds/Csr/Eph/2002. 2nd Edition https://apps.who.int/iris/bitstream/handle/10665/67350/WHO CDS CSR EPH 2002.12.pdf
  62. World Health Organization (2018) Antibiotics Resistance. WHO Fact sheet https://www.who.int/news-room/fact-sheet/detail/antibiotic-resistance
  63. Yamane, K., Wachino, J., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T. and Arakawa, Y. (2007). New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrobial Agents and Chemotherapy, 51: 3354–3360.
How to Cite

A., E. P., O, O. B., & R.O., B. (2020). Plasmid Mediated Quinolone Resistance in Enterobacteriaceae: A Review. Nigerian Journal of Microbiology, 34(1), 4962-4976. https://doi.org/10.67614/njm.2020.bboz4h02

E. P. A., O. B. O, and B. R.O., "Plasmid Mediated Quinolone Resistance in Enterobacteriaceae: A Review," Nigerian Journal of Microbiology, vol. 34, no. 1, pp. 4962-4976, June 2020. doi: 10.67614/njm.2020.bboz4h02

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles